Professor Lars Arendt-Nielsen, dr. med.sci., Ph.D., is founder and director of Center for Sensory-Motor Interaction (SMI), Aalborg University, Denmark and founder and director of R&D at the clinical trial unit C4Pain.
This interdisciplinary, internationally recognized translational pain research unit at SMI has been developed over the last 25 years with scientists coming from all over the world with 50% international researchers. Prof. Arendt-Nielsen’s group is the largest and most productive pain research groups in the world, with more than 70 researchers employed, he is the leading international researcher in the field of interdisciplinary translational and clinical pain research.
The research focus is on: 1) translational pain research, 2) human biomarkers for profiling pain patients, 3) development of human pain biomarkers for screening of new analgesic compounds, and 4) proof-of-concept and target validation studies on new analgesic compounds.
Dr. Arendt-Nielsen’s publication record counts 1,016 peer reviewed journal papers (sum of times cited 29,963 average citations per item 29.78, H-index 80, Web of Science). Furthermore, he has delivered over 260 keynote lectures at international meetings and seminars.
He has been visiting professor in Japan, Sweden, USA, and Italy.
Has served on the council of the International Association for the Study of Pain (IASP), co-president of the IASP Global Year Against Musculoskeletal Pain 2010, co-president of the IASP Global Year Against Joint Pain 2016, co-chair for IASP’s Special Interest Group (SIG) on Musculoskeletal Pain, head of the IASP Grant Committee, and Editor-in-Chief of IASP Press. In 2016 Dr. Arendt-Nielsen is elected President of IASP (period 2018-20).
In 2007 he was knighted by the Danish Queen for his contribution to science.